
|Articles|August 19, 2019
ASRS 2019 Street Team: Raj K. Maturi, MD
Author(s)Julianne Mobilian
ICYMI: Abicipar Phase II MAPLE Trial supports improved safety for patients with nAMD following a Modified Manufacturing Process
Advertisement
Raj K. Maturi, MD, discusses phase II data from the abicipar Phase II MAPLE Trial for patients with AMD at the 2019 annual ASRS conference.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Modern Retina
1
Clinical Trials at the Summit 2026: First-time data, AI, and the next generation of retinal treatments
2
The Retina TL;DR with Dr. Weng: Clinical trials, career, and community with David A. Eichenbaum, MD, FASRS
3
Geographic atrophy: When lesion borders cannot be graded
4
FDA guidance to help accelerate cell and gene therapies
5




















